RAM Investment Partners LLC Acquires New Position in Johnson & Johnson $JNJ

RAM Investment Partners LLC bought a new position in shares of Johnson & Johnson (NYSE:JNJ) during the 2nd quarter, according to its most recent disclosure with the SEC. The institutional investor bought 3,049 shares of the company’s stock, valued at approximately $466,000.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in the business. GFG Capital LLC purchased a new position in Johnson & Johnson in the second quarter valued at $35,000. Stone House Investment Management LLC purchased a new position in shares of Johnson & Johnson in the 1st quarter valued at about $47,000. 1248 Management LLC acquired a new position in shares of Johnson & Johnson during the first quarter worth about $48,000. Harvest Fund Management Co. Ltd purchased a new stake in shares of Johnson & Johnson during the first quarter worth approximately $52,000. Finally, Pandora Wealth Inc. acquired a new stake in Johnson & Johnson in the first quarter valued at approximately $65,000. Hedge funds and other institutional investors own 69.55% of the company’s stock.

Insider Buying and Selling at Johnson & Johnson

In other news, EVP Jennifer L. Taubert sold 56,471 shares of the firm’s stock in a transaction that occurred on Thursday, September 4th. The shares were sold at an average price of $177.81, for a total transaction of $10,041,108.51. Following the transaction, the executive vice president directly owned 178,013 shares in the company, valued at approximately $31,652,491.53. This trade represents a 24.08% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Insiders own 0.16% of the company’s stock.

Analysts Set New Price Targets

JNJ has been the subject of several analyst reports. Raymond James Financial boosted their price target on shares of Johnson & Johnson from $174.00 to $209.00 and gave the stock an “outperform” rating in a report on Wednesday, October 15th. Wall Street Zen upgraded shares of Johnson & Johnson from a “hold” rating to a “buy” rating in a research note on Saturday, September 13th. Erste Group Bank upgraded Johnson & Johnson from a “hold” rating to a “buy” rating in a research note on Wednesday, July 23rd. Morgan Stanley set a $190.00 price objective on Johnson & Johnson in a research report on Wednesday, October 15th. Finally, Daiwa America upgraded Johnson & Johnson from a “hold” rating to a “strong-buy” rating in a report on Monday, October 20th. Four analysts have rated the stock with a Strong Buy rating, fourteen have given a Buy rating and nine have assigned a Hold rating to the company’s stock. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and an average price target of $200.52.

Johnson & Johnson Stock Performance

NYSE JNJ opened at $195.19 on Friday. The company has a fifty day moving average of $185.46 and a two-hundred day moving average of $169.66. The company has a market capitalization of $470.27 billion, a PE ratio of 18.84, a P/E/G ratio of 2.19 and a beta of 0.38. Johnson & Johnson has a 1 year low of $140.68 and a 1 year high of $196.00. The company has a debt-to-equity ratio of 0.50, a current ratio of 1.07 and a quick ratio of 0.80.

Johnson & Johnson (NYSE:JNJ) last posted its earnings results on Wednesday, August 30th. The company reported $2.26 earnings per share for the quarter. The business had revenue of $24.02 billion during the quarter. Johnson & Johnson had a return on equity of 32.73% and a net margin of 27.26%. As a group, analysts expect that Johnson & Johnson will post 10.58 earnings per share for the current year.

Johnson & Johnson Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 9th. Stockholders of record on Tuesday, November 25th will be issued a $1.30 dividend. This represents a $5.20 annualized dividend and a dividend yield of 2.7%. The ex-dividend date of this dividend is Tuesday, November 25th. Johnson & Johnson’s dividend payout ratio is presently 50.19%.

Johnson & Johnson Profile

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension.